Literature DB >> 23351035

Nicotine-motivated behavior in Caenorhabditis elegans requires the nicotinic acetylcholine receptor subunits acr-5 and acr-15.

Laurie Sellings1, Schreiber Pereira, Cheng Qian, Thomas Dixon-McDougall, Christina Nowak, Bin Zhao, Rachel F Tyndale, Derek van der Kooy.   

Abstract

Signaling at nicotinic acetylcholine receptors in Caenorhabditis elegans controls many behaviors, including egg-laying and locomotor activity. Here, we show that C. elegans approaches a point source of nicotine in a time-, concentration- and age-dependent manner. Additionally, nicotine paired with butanone under starvation conditions prevented the reduced approach to butanone that is observed when butanone is paired with starvation alone and pairing with nicotine generates a preference for the tastes of either sodium or chloride over baseline. These results suggest nicotine acts as a rewarding substance in C. elegans. Furthermore, the nicotinic receptor antagonist mecamylamine, the smoking cessation pharmacotherapy varenicline, mutation of the dop-1 and dop-2 dopamine receptors, and mutations of either acr-5 or acr-15, two nicotinic receptor subunit genes with sequence homology to the mammalian α7 subunit, all reduced the nicotine approach behavior. These two mutants also were defective at associating the presence of nicotine with butanone under starvation conditions and acr-5 mutation could obviate the effect of pairing nicotine with salts. Furthermore, the approach deficit in acr-15 mutants was rescued by selective re-expression in a subset of neurons, but not in muscle. Caenorhabditis elegans may therefore serve as a useful model organism for nicotine-motivated behaviors that could aid in the identification of novel nicotine motivational molecular pathways and consequently the development of novel cessation aids.
© 2013 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23351035     DOI: 10.1111/ejn.12099

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

1.  Insulin signaling genes modulate nicotine-induced behavioral responses in Caenorhabditis elegans.

Authors:  Seth A Wescott; Elizabeth A Ronan; X Z Shawn Xu
Journal:  Behav Pharmacol       Date:  2016-02       Impact factor: 2.293

2.  Caenorhabditis elegans as a model system to identify therapeutics for alcohol use disorders.

Authors:  Simon N Katner; Kristin E Bredhold; Kevin B Steagall; Richard L Bell; Bethany S Neal-Beliveau; Mi C Cheong; Eric A Engleman
Journal:  Behav Brain Res       Date:  2019-02-22       Impact factor: 3.332

Review 3.  Neurotransmitter signaling through heterotrimeric G proteins: insights from studies in C. elegans.

Authors:  Michael R Koelle
Journal:  WormBook       Date:  2018-12-11

4.  Drug-dependent behaviors and nicotinic acetylcholine receptor expressions in Caenorhabditis elegans following chronic nicotine exposure.

Authors:  Joseph R Polli; Dorothy L Dobbins; Robert A Kobet; Mary A Farwell; Baohong Zhang; Myon-Hee Lee; Xiaoping Pan
Journal:  Neurotoxicology       Date:  2014-12-19       Impact factor: 4.294

5.  MicroRNA Regulation of nAChR Expression and Nicotine-Dependent Behavior in C. elegans.

Authors:  Manish Rauthan; Jianke Gong; Jinzhi Liu; Zhaoyu Li; Seth A Wescott; Jianfeng Liu; X Z Shawn Xu
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

Review 6.  Caenorhabditis elegans as a Model to Study the Molecular and Genetic Mechanisms of Drug Addiction.

Authors:  Eric A Engleman; Simon N Katner; Bethany S Neal-Beliveau
Journal:  Prog Mol Biol Transl Sci       Date:  2015-11-24       Impact factor: 3.622

Review 7.  Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification.

Authors:  Robert A Kobet; Xiaoping Pan; Baohong Zhang; Stephen C Pak; Adam S Asch; Myon-Hee Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-09-30       Impact factor: 4.634

8.  Caenorhabditis elegans Show Preference for Stimulants and Potential as a Model Organism for Medications Screening.

Authors:  Eric A Engleman; Kevin B Steagall; Kristin E Bredhold; Michaela Breach; Hannah L Kline; Richard L Bell; Simon N Katner; Bethany S Neal-Beliveau
Journal:  Front Physiol       Date:  2018-08-30       Impact factor: 4.566

9.  Track-a-worm, an open-source system for quantitative assessment of C. elegans locomotory and bending behavior.

Authors:  Sijie Jason Wang; Zhao-Wen Wang
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype.

Authors:  Rajani Kanteti; Immanuel Dhanasingh; Essam El-Hashani; Jacob J Riehm; Thomas Stricker; Stanislav Nagy; Alexander Zaborin; Olga Zaborina; David Biron; John C Alverdy; Hae Kyung Im; Shahid Siddiqui; Pamela A Padilla; Ravi Salgia
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.